Paasa Logo
Invesco Biotechnology & Genome ETF logo
PBEAMEXMarket closedOpens 9:30am ET

Invesco Biotechnology & Genome ETF

$97.12Last updated
-$0.04 (0.05%)Past day
Timezone

Invesco Biotechnology & Genome ETF (AMEX: PBE) is an exchange-traded fund listed on NYSE Arca, trading at $97.12 (about ₹9,324 a unit) as of 30 Sep 2026, 3:59 PM ET. It has an expense ratio of 0.59% and holds 31 securities. Indian residents can buy PBE through Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$96.83
Previous close:$97.16
Volume:11.65K

Today's low

$96.71

Today's high

$98.00

52 week low

$69.95

52 week high

$98.82

PBE opened at $96.83, closed previously at $97.16, and has traded between $69.95 and $98.82 over the past 52 weeks.

About

The Invesco Biotechnology & Genome ETF (PBE) seeks to replicate the performance of the Dynamic Biotech & Genome Intellidex Index. This fund typically allocates a minimum of 90% of its total assets to the securities comprising the underlying index. The Index is constructed to achieve capital appreciation by thoroughly evaluating companies based on several investment criteria, including their price momentum, earnings growth, overall quality, management decisions, and valuation. It consists of 30 U.S.-based companies within the biotechnology and genome sectors. These companies are primarily involved in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, or they are businesses that stand to gain significantly from scientific and technological breakthroughs in biotechnology and genetic engineering. Both the ETF and its benchmark index undergo quarterly rebalancing and reconstitution in February, May, August, and November.

Issuer
Invesco
Exchange listed on
AMEX
Asset class
Equity
Base currency
USD
Domicile
United States
Dividends
Distributing
Launched
2005
ISIN
US46137V7872

Key statistics

Expense ratio

0.59%

Assets (AUM)

$423.7M

Holdings

31

NAV

$97.18

Avg. volume

—

1-year price change

+39.00%

5-year price change

+30.14%

Price change excludes dividends.

Top 10 holdings

1. Natera Inc
6.2%
2. Illumina Inc
6.1%
3. Biogen Inc
5.2%
4. Gilead Sciences Inc
5.2%
5. Amgen Inc
4.9%
6. Vertex Pharmaceuticals Inc
4.8%
7. Royalty Pharma PLC
4.8%
8. Regeneron Pharmaceuticals Inc
4.6%
9. Moderna Inc
3.5%
10. Novavax Inc
3.2%

PBE holds 31 securities in total. These 10 are 48.5% of the fund.

Where the money is invested

Sectors

Healthcare
99.9%
Financial Services
0.1%

Countries

United States
97.1%
Netherlands
2.9%
Other
0.1%

How to buy PBE from India

Indian residents can buy PBE units through Paasa in three steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the units are held in your own name with Interactive Brokers.

  1. Open your Paasa account

    KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds from your Indian bank account

    Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit.

  3. Search PBE and buy

    Find the fund by its ticker, PBE, on NYSE Arca, and place your order. Fractional units are available and there is no minimum trade size, so you can buy by amount.

Read the full guide: how to invest in PBE from India

Trading and taxes when buying PBE from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on foreign ETF units held for more than 24 months are long-term and taxed at 12.5% without indexation. Gains on units held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
Slab rateIt pays the dividends from its holdings out to you in cash, and dividends are taxed at your slab rate in India. The US withholds tax on dividends paid to Indian residents at the treaty rate; Paasa files Form W-8BEN for you, and the tax withheld can generally be claimed as a credit in India.Dividend tax explained
US estate tax
May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator

Custody. Units are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

What is the PBE price today?

Invesco Biotechnology & Genome ETF (PBE) last traded at $97.12 on NYSE Arca, as of 30 Sep 2026, 3:59 PM ET. That is ₹9,324 a unit at the 30 Sep 2026 USD/INR rate.

When does PBE trade, in Indian time?

NYSE Arca trades 7:00 pm – 1:30 am IST, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

How big is PBE, and what does it cost to hold?

Invesco Biotechnology & Genome ETF manages about $423.7M. Its expense ratio is 0.59% a year, deducted inside the fund. It launched in 2005.

What are PBE's largest holdings?

The top three are Natera Inc (6.2%), Illumina Inc (6.1%) and Biogen Inc (5.2%). PBE's 10 largest positions make up 48.5% of the fund.

Does PBE pay dividends?

Yes. PBE is a distributing fund and pays the dividends from its holdings out in cash. In India they are taxed at your slab rate. The US withholds 25% tax on dividends before they reach you; Paasa files Form W-8BEN for you, and the tax withheld can generally be claimed as a credit when you file in India.

How are gains on PBE taxed in India?

Units held for more than 24 months are long-term and taxed at 12.5% without indexation; units held for 24 months or less are taxed at your income-tax slab rate. The gain is worked out in rupees, so the currency move counts.

Can I buy fractional units of PBE?

Yes. You can buy PBE by amount rather than by whole unit, and there is no minimum trade size.

How has PBE performed?

PBE's price is up 39.0% over the past year and up 30.1% over five years. These figures are price change only and exclude dividends; past performance does not guarantee future returns.